siRNA Therapeutics Market: By Delivery Technology (GalNAc Conjugate, Lipid Nanoparticle, Polymer/Other); Route (Subcutaneous, Intravenous, Intrathecal/CNS); Indication (Rare/Metabolic: hATTR Amyloidosis, Hyperoxaluria, Porphyria; Cardiovascular/Dyslipidemia; Oncology; Others); Distribution Channel (Hospital Pharmacy, Specialty Pharmacy); End User (Hospitals, Specialty Clinics, Homecare)—Market Size, Industry Dynamics, Opportunity Analysis and Forecast For 2026–2035
The siRNA therapeutics market is estimated at USD 2.1 billion in 2025 and is projected to reach USD 9.0 billion by 2035, growing at a CAGR of 15.7% over the forecast period 2026–2035. Read More
We Are Trusted By These Great Companies!
- Last Updated: 23-Jul-2026 | Format:
![pdf]()
![powerpoint]()
![excel]()
| Report ID: AA07261898
| Report ID: AA07261898inquire-before-purchase
Base Year 2025
Historic Year 2020 - 2024
Forecast Year 2026-2035
No Of Pages 260
Total Figures 100
Total Tables 900
Features | Type of License | ||||
 Data Book | Single User |   Multi User |  Corporate | ||
| e-Access | ✓ | ✓ | ✓ | ✓ | |
User Sharing | 1 User Only | 1 User Only | Up to 7 Users | Unlimited User Access | |
⨉ | ⨉ | ⨉ | ✓ | ||
Free Customization | No Free Customization | Up To 30 hrs work | Up To 60 hrs work | Up To 80 hrs work | |
Deliverable |
| ⨉ | ✓ | ✓ | ✓ |
| ✓ | ⨉ | ✓ | ✓ | |
| ⨉ | ⨉ | ⨉ | ✓ | |
Analyst Support | 2-Months Analyst Support | 4-Months Analyst Support | 7-Months Analyst Support | One Year Analyst Support | |
Free Report update in next update cycle | ⨉ | ⨉ | ⨉ | ✓ | |
Free Industry Update (Within 180 days) | ⨉ | ⨉ | ⨉ | ✓ | |
Benefit | Up to 10% off on Post Purchase | Up to 20% off on Post Purchase | Up to 30% off on Post Purchase | Up to 40% off on Post Purchase | |
